MedPath

Peritoneal Dialysis Versus Haemodialysis

Not Applicable
Completed
Conditions
Hemodialysis
Interventions
Procedure: Haemodialysis
Procedure: Peritoneal dialysis
Registration Number
NCT00752583
Lead Sponsor
University Hospital, Ghent
Brief Summary

Study in order to quantify toxin removal during dialysis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Substudy 1: includes new starting dialysis patients on peritoneal dialysis PD or haemodialysis HD
  • Substudy 2: stabile haemodialysis patients and peritoneal dialysis patients. Patients will be matched for gender, time on dialysis, diabetes, renal function at the start of dialysis.
  • Substudy 3: patients on CAPD (continuous ambulant PD) or CCPD (continuous cyclic PD).
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
2HaemodialysisHaemodialysis
1Peritoneal dialysisPeritoneal dialysis
Primary Outcome Measures
NameTimeMethod
Registration of toxin removal efficiencyAfter 1 week and after 1, 3, 6, 9, 12, 18 and 24 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Ghent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath